This page is not available in English

You must accept marketing cookies to share the page by mail

Update consent

Share by mail

Your email: Recipient's email:

Click here to see the Danish page 'Mavenclad (cladribin): Risiko for alvorlig leverskade og nye anbefalinger vedrørende monitorering af leverfunktion' Go to English frontpage